Clinical Trials
Raising Minority Enrollment With Creativity And Collaboration
By Van R. Johnson, ABA, BA, vice president commercial strategy, Benchmark Research
The growing need for increased diversity in clinical trials has ...
Only 1 of 25 cancer drug developers fairly included minority patients over five-year window, BMJ analysis finds
New clinical trial diversity plans, which FDA will soon explain further, were featured in the government spending package that President Joe Biden ...
Continuous Glucose Monitoring Plus an Online Peer Support Community Reinforces Healthy Behaviors in Hispanic Adults With Type 2 Diabetes
Background:
Previous research has suggested beneficial glycemic outcomes for people with type 2 diabetes with the use of continuous ...
Telmisartan Use Impacts Alzheimer Disease Risk in African American Patients
Exposure to telmisartan reduced the incidence of Alzheimer disease (AD), specifically among older African American patients, according to findings ...
Sex, Racial, and Ethnic Representation in COVID-19 Clinical Trials
Question  Compared with their representation in the US population with COVID-19, are female participants and racial and ethnic minority persons und...
A look at Black and Hispanic Americans’ views on clinical trials
A participant in a phase three clinical trial receives a COVID-19 vaccine at the Research Centers of America in Hollywood, Florida, in August 2020....
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
